Matthew Shair, Director at Nuvalent, Inc. (NUVL), sold 75,000 shares at $65.42 ($4.9M) on 2024-05-13, disclosed to the SEC on 2024-05-15.
Scheduled sale ($4.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.42 | 19,909 | $1.3M | 26.4% |
| 2 | $65.42 | 19,909 | $1.3M | 26.4% |
| 3 | $66.12 | 13,129 | $868K | 17.6% |
| 4 | $66.12 | 13,129 | $868K | 17.6% |
| 5 | $66.86 | 4,462 | $298K | 6.0% |
| 6 | $66.86 | 4,462 |
| $298K |
| 6.0% |
| Total | $65.84 avg | 75,000 | $4.9M | 100% |
| Filing → |
| NUVL | SELL | 2025-02-25 | $265K | — | Filing → |
| NUVL | SELL | 2025-01-29 | $302K | — | Filing → |
| NUVL | SELL | 2024-12-26 | $285K | — | Filing → |